--2024/Q4-- / 333.330K--
--2024/Q3-- / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
Mar 12, 20242023/Q42.009M / 1.600M--
US Stock MarketDetailed Quotes
ALGS Aligos Therapeutics
- 7.620
- +0.730+10.60%
Close Oct 11 16:00 ET
- 7.620
- 0.0000.00%
Post 20:01 ET
24.35MMarket Cap-525P/E (TTM)
7.700High6.850Low62.68KVolume6.850Open6.890Pre Close455.26KTurnover4.28%Turnover RatioLossP/E (Static)3.20MShares30.00052wk High0.36P/B11.17MFloat Cap6.76052wk Low--Dividend TTM1.47MShs Float937.748Historical High--Div YieldTTM12.34%Amplitude6.760Historical Low7.262Avg Price1Lot Size
Aligos Therapeutics Key Stats
Aligos Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Aligos Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
